Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Gene Therapy Moratorium topic
No spam. Unsubscribe anytime.
Committee agrees to print RS 31966, a proposed moratorium on experimental gene-therapy immunizations
Summary
Sen. Brandon Shippey introduced RS 31966 — styled the 'Doug Cameron Act' — proposing a temporary moratorium on experimental human gene therapy products used as immunizations for infectious disease indications pending a safety review; the committee voted to print the RS.
Sen. Brandon Shippey presented RS 31966 to the Senate Health and Welfare Committee, describing it as a temporary moratorium on experimental human gene therapy products being used as immunizations for infectious disease indications.
Shippey said the legislation is named in honor of Doug Cameron, whom the sponsor described as an Idaho rancher who experienced severe adverse effects after receiving a "genetic immunization." Shippey said the proposed moratorium would pause the use of such products for infectious disease indications while legislators can review their safety and long-term effects. The bill text includes an exemption on a second page, the sponsor said, and Shippey told the committee he will bring experts to the formal hearing to answer technical questions.
Senator Melissa Wintrow voiced support for the sponsor but asked for clarification at the hearing about scope, consent, and which infections and products the moratorium would cover. Shippey said he would be prepared to answer those questions at the hearing.
Senator Lenny moved to send RS 31966 to print and Senator Keiser seconded; the committee approved the motion by voice vote.
